About the company
Since our launch in 2013, we have invested ~$50 billion in research to discover, develop and deliver new medicines. We target diseases with significant unmet need where we can improve the standard of care with innovative new therapies. We're constantly working to create solutions that go beyond treating the illness to have a positive impact on patients lives, on societies and on science itself. We care deeply for patients and customers, their families, our employees, and our communities. We strive to always do the right thing, pursuing the highest standards in quality, compliance, safety, and performance. We embrace diverse backgrounds and perspectives and treat everyone equally, with dignity and respect, allowing us all to achieve our best.
open roles
Browse all jobsLatest Articles and Interviews
View More
Policy, Talent and Innovation Are Fueling Pennsylvania's Life Sciences Growth
Affordable Semaglutide Set to Reshape India’s Workplace Health Landscape
Preparing Nurses for Global Careers: BorderPlus Introduces AI-Driven Nurse Companion
“There are talent shortages in specialised modalities such as ADCs, peptides, and computational biology”

